Cara Therapeutics (NASDAQ:TVRD) Stock Rating Upgraded by Wall Street Zen
Cara Therapeutics (NASDAQ:TVRD – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “hold” rating in a research note issued on Saturday. Cara Therapeutics Stock Down 11.5% NASDAQ:TVRD opened at $29.09 on Friday. Cara Therapeutics Company Profile (Get Free Report) Cara Therapeutics, Inc, an early commercial-stage biopharmaceutical company, focuses on […]
Cara Therapeutics (NASDAQ:TVRD – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “hold” rating in a research note issued on Saturday. Cara Therapeutics Stock Down 11.5% NASDAQ:TVRD opened at $29.09 on Friday. Cara Therapeutics Company Profile (Get Free Report) Cara Therapeutics, Inc, an early commercial-stage biopharmaceutical company, focuses on […]
